IMCD Beheer

Beheer criteriumcontroles 2/4

De CEO IMCD is Valerie Diele-Braun, benoemd in Oct2023, heeft een ambtstermijn van 1.08 jaar. De totale jaarlijkse vergoeding van { bedraagt € 2.27M, bestaande uit 9.4% salaris en 90.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.01% van de aandelen van het bedrijf, ter waarde € 823.68K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.8 jaar en 4.5 jaar.

Belangrijke informatie

Valerie Diele-Braun

Algemeen directeur

€2.3m

Totale compensatie

Percentage CEO-salaris	9.4%
Dienstverband CEO	1.1yrs
Eigendom CEO	0.01%
Management gemiddelde ambtstermijn	1.8yrs
Gemiddelde ambtstermijn bestuur	4.5yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Valerie Diele-Braun's beloning veranderd ten opzichte van IMCD's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	€281m
Mar 31 2024	n/a	n/a	€287m
Dec 31 2023	€2m	€213k	€292m
Sep 30 2023	n/a	n/a	€290m
Jun 30 2023	n/a	n/a	€289m
Mar 31 2023	n/a	n/a	€301m
Dec 31 2022	€70k	n/a	€313m
Sep 30 2022	n/a	n/a	€296m
Jun 30 2022	n/a	n/a	€279m
Mar 31 2022	n/a	n/a	€243m
Dec 31 2021	€63k	n/a	€207m
Sep 30 2021	n/a	n/a	€184m
Jun 30 2021	n/a	n/a	€162m
Mar 31 2021	n/a	n/a	€141m
Dec 31 2020	€30k	n/a	€120m

Compensatie versus markt: De totale vergoeding ($USD 2.37M ) Valerie } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de UK markt ($USD 3.23M ).

Compensatie versus inkomsten: De beloning van Valerie is het afgelopen jaar met meer dan 20% gestegen, terwijl de winst van het bedrijf met meer dan 20% is gedaald.

CEO

Valerie Diele-Braun (53 yo)

1.1yrs

Tenure

€2,273,000

Compensatie

Ms. Valerie Diele-Braun was Chief Executive Officer of CABB GmbH since August 27, 2018. Ms. Diele-Braun was the President of Packaging & Paper Specialties and Coatings, Adhesives & Sealants at Archroma Man...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Valerie Diele-Braun	CEO & Member of Management Board	1.1yrs	€2.27m	0.010% € 823.7k
Hans J. Kooijmans	CFO & Member of Management Board	28.8yrs	€1.41m	0.066% € 5.2m
Marcus Jordan	COO & Member of Management Board	2.5yrs	€1.51m	0.023% € 1.9m
Laurens Dalmijin	General Counsel	no data	geen gegevens	geen gegevens
Olivier Champault	President of IMCD France & Business and Group Director of Advanced Materials	6.8yrs	geen gegevens	geen gegevens
Swapna Kattewar	Head of Global Regulatory Questionnaire Centre	no data	geen gegevens	geen gegevens
Andreas Igerl	President of APAC	less than a year	geen gegevens	geen gegevens
Arturo Hoyo	Managing Director of IMCD Mexico	less than a year	geen gegevens	geen gegevens
Cecile Westerhuis	Company Secretary	no data	geen gegevens	geen gegevens

1.8yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van IMCDA wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.8 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Janus Smalbraak	Independent Chairman of Supervisory Board	8.5yrs	€105.00k	geen gegevens
Stephan Nanninga	Independent Vice Chairman of the Supervisory Board	6.5yrs	€75.00k	geen gegevens
Willem Eelman	Member of Supervisory Board	2.5yrs	€70.00k	geen gegevens
Dorthe Mikkelsen	Supervisory Board Member	less than a year	€5.00k	geen gegevens

4.5yrs

Gemiddelde duur

58.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van IMCDA wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.5 jaar).

IMCD Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

IMCD N.V., Annual General Meeting, Apr 25, 2025

IMCD Appoints Dorthe Mikkelsen as Member of the Supervisory Board

IMCD Appoints Dorthe Mikkelsen as Member of the Supervisory Board

IMCD N.V. Appoints Marcus Jordan as Chief Operating Office and New Member of the Management Board

IMCD N.V. Announces Management Changes, Effective 26 February 2021

Recent updates

IMCD N.V. has filed a Follow-on Equity Offering in the amount of €300 million.

IMCD N.V. to Report Q1, 2025 Results on Apr 25, 2025

IMCD N.V. (ENXTAM:IMCD) agreed to acquire Blumos Group.

IMCD N.V., Annual General Meeting, Apr 25, 2025

IMCD N.V. Approves Dividend for the Year 2023, Payable on 21 May 2024

Upcoming dividend of €2.24 per share

Full year 2023 earnings released: EPS: €5.14 (vs €5.50 in FY 2022)

IMCD N.V. to Report Q1, 2024 Results on Apr 26, 2024

New minor risk - Insider selling

IMCD N.V. (ENXTAM:IMCD) acquired 70% stake in Valuetree Ingredients Private Limited from the founders of Valuetree Ingredients Private Limited.

IMCD Appoints Dorthe Mikkelsen as Member of the Supervisory Board

IMCD Appoints Dorthe Mikkelsen as Member of the Supervisory Board

IMCD N.V. to Report First Half, 2024 Results on Aug 02, 2024

First half 2023 earnings released: EPS: €2.68 (vs €3.11 in 1H 2022)

IMCD N.V. to Report Q1, 2024 Results on Apr 26, 2024

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Sachs Chemical, Inc.

IMCD N.V. (ENXTAM:IMCD) agreed to acquire Brylchem Group.

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Euro Chemo-Pharma Sdn. Bhd.

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Koi Products Solutions & Engineering Ltd.

Upcoming dividend of €2.37 per share at 1.6% yield

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire CPS Chemical Oil-Tech (Pty) Ltd.

IMCD N.V. (ENXTAM:IMCD) entered into an agreement to acquire Parkash DyeChem Private Limited.

IMCD N.V. to Report First Half, 2023 Results on Aug 04, 2023

Now 20% undervalued after recent price drop

Now 22% undervalued

IMCD N.V. (ENXTAM:IMCD) acquired 100% of the shares in Kuni Chemical Co., Ltd.

First half 2022 earnings released

IMCD N.V. to Report Q1, 2023 Results on Apr 26, 2023

IMCD N.V. (ENXTAM:IMCD) has signed an agreement to acquire Welex S.A. Holdings (China) Limited.

IMCD N.V. Appoints Marcus Jordan as Chief Operating Office and New Member of the Management Board

IMCD Stops Its Business in Russia

Upcoming dividend of €1.62 per share

IMCD N.V. Proposes Dividend for the Year 2021

IMCD N.V. (ENXTAM:IMCD) agreed to acquire Quelaris Internacional S.A.

Investor sentiment deteriorated over the past week

IMCD N.V. (ENXTAM:IMCD) agreed to acquire Polychem Handelsgesellschaft M.B.H.

First half 2021 earnings released: EPS €1.85 (vs €1.22 in 1H 2020)

IMCD N.V. (ENXTAM:IMCD) entered into an agreement to acquire Materias Quimicas De Mexico, S.A. De C.V.

Independent Member of Supervisory Board Michel G. Plantevin has left the company

Upcoming dividend of €1.02 per share

IMCD N.V. (ENXTAM:IMCD) acquired Shanghai Yuanhe Chemicals Co., Ltd.

IMCD N.V. (ENXTAM:IMCD) acquired Andes Chemical Corp.

New 90-day high: €112

Full year 2020 earnings released: EPS €2.25 (vs €2.06 in FY 2019)

Revenue beats expectations

Full year 2020 earnings released: EPS €2.25 (vs €2.06 in FY 2019)

Revenue beats expectations

IMCD N.V. Announces Management Changes, Effective 26 February 2021

IMCD N.V. (ENXTAM:IMCD) acquired Millikan S.A. de C.V. and Banner Química S.A. de C.V.

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire the personal care business of Ejder Kimya Ilaç Danismanlik Sanayi ve Ticaret A.S.

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Pharmaceutical Business of Peak International Products B.V.

IMCD N.V. (ENXTAM:IMCD) acquired Oy Kokko-Fiber Ab.

IMCD N.V. has completed a Follow-on Equity Offering in the amount of €399.999964 million.

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Siyeza Fine Chem Propriety Limited.

IMCD N.V. (ENXTAM:IMCD) completed the acquisition of pharmaceutical business of Develing International Trade (Shanghai) Co. Ltd.

IMCD N.V. (ENXTAM:IMCD) acquired VitaQualy Comercio de Ingredientes LTDA.

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd